FOOD AND DRUG ADMINISTRATION
CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)
Cardiovascular and Renal Drugs Advisory Committee
The committee will discuss class labeling of antihypertensive drugs based on the proximity of their data to outcome trials
Applicable Outcomes Claims Stephen W. MacMahon, B.Sc., Ph.D., M.P.H., F.A.C.C.
For Antihypertensive Drugs Principal Director
The George Institute for International Health
Differences in Outcomes Claims Stephen W. MacMahon, B.Sc., Ph.D., M.P.H., F.A.C.C.
For Different Drug Classes
Deciding Whom to Treat Jay N. Cohn, M.D.
For Hypertension Professor of Medicine and Director
When to Initiate Successive Henry R. Black, M.D.
Antihypertensive Drugs Chairman and Associate Vice President for Research
Can One Sustain an Outcome
Claim Based on an Active
Introduction Lance Berman, MD
Medical Director –
Methodology and Analysis Michael Gaffney, Ph.D.
[Overview] Senior Director – Statistical Research and Consulting
Does the Pattern of Blood Thomas G. Pickering, M.D., Ph.D., F.R.C.P.
Pressure Effects During the Director – Integrative and Behavioral Cardiology Program
Day Matter? The Zena and Michael A. Wiener Cardiovascular Institute
Does the Benefit Associated with Ronald J. Portman, M.D.
Treating Hypertension Apply to Professor of Pediatrics and Director of the Division
Children? Pediatric Nephrology and Hypertension